These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3928210)

  • 1. Prolactin secretion and biological activity in females with galactorrhoea and normal circulating prolactin concentrations at rest.
    Johnston DG; Haigh J; Prescott RW; Heaton A; Kendall-Taylor P; Baylis P; Alberti KG; Rowe R; Friesen H; Cook D
    Clin Endocrinol (Oxf); 1985 May; 22(5):661-78. PubMed ID: 3928210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
    Jeske W
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Prl release in galactorrhoeic normoprolactinaemic women.
    D'Agata R; Aliffi A; Maugeri G; Mongioì A; Vicari E; Gulizia S
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):1-4. PubMed ID: 6812343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incomplete autonomy of prolactin secretion in a case of pituitary adenoma with transient galactorrhea].
    Jeske W; Kasperlik-Zaluska A
    Endokrynol Pol; 1977; 28(2):151-4. PubMed ID: 404134
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
    Smith CR; Butler J; Hashim I; Norman MR
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactorrhoea-amenorrhoea and hyperprolactinaemia: pathophysiological aspects and diagnostic tests.
    Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():81S-89S. PubMed ID: 568528
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts of prolacting physiology in normal and abnormal conditions.
    Archer DF
    Fertil Steril; 1977 Feb; 28(2):125-34. PubMed ID: 401746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactorrhea in sarcoidosis: dynamic studies of prolactin, growth and gonadotropic hormone levels.
    Caro JF; Israel HL; Glennon JA
    Am J Med Sci; 1979; 277(3):289-94. PubMed ID: 110148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.
    Glass MR; Shaw RW; Butt WR; Edwards RL; London DR
    Br Med J; 1975 Aug; 3(5978):274-5. PubMed ID: 1170923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aetiology of galactorrhoea in women with regular menstruation and normal prolactin levels.
    Abdel Gadir A; Khatim MS; Muharib NS; Shaw RW
    Hum Reprod; 1992 Aug; 7(7):912-4. PubMed ID: 1430126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dosage of prolactin in normal and pathological subjects (author's transl)].
    Franchimont P; Dourcy C; Legros JJ; Reuter A; Vrindts-Gevaert Y; van Cauwenberge JR; Remacle P; Gaspard U; Colin C
    Ann Endocrinol (Paris); 1976; 37(3):127-56. PubMed ID: 828474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of prolactin secretion in idiopathic galactorrhea].
    Iannotta F; Rizzuto G; Colombo F; Visconti G; Giuliani F; Parabiaghi R
    Minerva Endocrinol; 1989; 14(2):119-23. PubMed ID: 2761495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
    Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease.
    Rose DP; Berke B; Cohen LA; Lahti H
    Cancer; 1987 Dec; 60(11):2761-5. PubMed ID: 3119186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.